For safety and patient information relating to GSK products not listed below, please refer to www.medicines.ie
Showing refined by:
-
Anoro▼Ellipta (umeclidinium/vilanterol inhalation powder) | GSK Pharma Ireland | Public Site
Anoro▼Ellipta (umeclidinium/vilanterol inhalation powder) product overview for members of the public in the Republic of Ireland -
Avamys (fluticasone furoate)| GSK Pharma Ireland | Public Site
Avamys (fluticasone furoate) Product overview for members of the public in the Republic of Ireland -
Dovato (dolutegravir/lamivudine) | GSK Pharma Ireland | Public Site
Dovato (dolutegravir/lamivudine) product overview for members of the public in the Republic of Ireland -
Ellipta Device | GSK Pharma Ireland | Public Site
Ellipta device overview for members of the public in the Republic of Ireland -
Incruse▼Ellipta (umeclidinium inhalation powder) | GSK Pharma Ireland | Public Site
Incruse▼Ellipta (umeclidinium inhalation powder) product overview for members of the public in the Republic of Ireland -
Nucala(mepolizumab) | GSK Pharma Ireland | Public Site
Nucala(mepolizumab) product overview for members of the public in the Republic of Ireland -
Relvar Ellipta(fluticasone furoate/vilanterol inhalation powder) | GSK Pharma Ireland | Public Site
Relvar Ellipta(fluticasone furoate/vilanterol inhalation powder) patient information for members of the public in the Republic of Ireland -
Rotarix (Rotavirus vaccine, live) | GSK Pharma Ireland | Public Site
Rotarix (Rotavirus vaccine, live) product overview for members of the public in the Republic of Ireland -
Shingrix▼(Herpes zoster vaccine (recombinant, adjuvanted))
Information on Shingrix▼ (herpes zoster vaccine, recombinant adjuvanted) for members of the public in Ireland -
Volibris (ambrisentan) | GSK Pharma Ireland | Public Site
Volibris (ambrisentan) product overview for members of the public in the Republic of Ireland
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
There are no results matching your refine settings
Show more
▼ These medicinal products are subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting side effects you may get.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this website or in the product package leaflet. You can also report side effects directly to HPRA Pharmacovigilance on their website: www.hpra.ie.
By reporting side effects, you can help provide more information on the safety of this medicine.
Trademarks are owned by or licensed to the GSK group of companies.
CB Last Updated: June 2021. NP-IE-NA-WCNT-210001